摘要:
The invention relates to the use of nucleic acid miRNA derived molecules for producing a drug for treating a myelogenous leukemia and to a method for identifying therapeutic agents or the efficient combination thereof for inducing the differentiation of myelogenous leukemia cells.
摘要:
The invention relates to compositions comprising a retinoid X receptor agonist and an agent capable of activating protein kinase A. The invention also relates to methods of treating hyperproliferative diseases by administering a retinoid X receptor agonist and an agent capable of activating protein kinase A.
摘要:
A gamma radiation cell for sterilizing industrial products, of the type constituted by a shielded enclosure provided with at least one tight access door, comprising an overhead conveyor for displacing transports supporting the products to be treated. The floor of the enclosure comprises a central well allowing storage of a source of irradiation which may be moved vertically. Pipes connect this well to an oxygen reserve and to a reservoir for storing the ozone produced by radiolysis, this ozone being able to be admitted into the vessel of the transports.
摘要:
The invention concerns permanent cell lines of human promyelocyte cells characteristic of acute promyelocytic leukemias, these cells being cytogenetically characterized by a translocation t(15;17), capable of indefinite proliferation in a culture medium. It also concerns the use of these cell lines, particularly for screening molecules capable of inducing cell maturation.